The patient number and the prevalence of high AG among the 1733 CKD stage 5 patients were 1177 (67.9%), 1596 (92.1%) and 1688 (97.4%) for the traditional > 12.42 mEq/L (Fig. 2a right area), albumin-adjusted > 1.47 mEq/L (Fig. 2a upper area) and full AG > 5.69 mEq/L (Fig. 2b upper area), respectively. This evidence concerns the gene ALB and chronic kidney disease.